Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
"Insulin resistance, obesity and lipotoxicity." Adv Exp Med Biol 2017;960:277-304
Study limitations Although the current findings are consistent and coherent, strongly indicating the external validity of the study, we do recommend future preferably large prospective clinical trials, to increase their internal validity
As research grows, patients have more choices to match their needs and goals
The American Journal of Clinical Nutrition, 112 (1), 229
Mayo Foundation for Medical Education and Research (MFMER)
US$ 28.89
US$ 28.84
US$ 21.65
US$ 20.71
US$ 23.23
US$ 21.16
